Equidyne Corporation and Rite Aid Expand Their Retail Marketing Partnership
Equidyne and Rite Aid Corporation to Promote INJEX(TM) Directly to
Customers with Diabetes Through Its Retail Pharmacies Nationwide
SAN DIEGO and CAMP HILL, Pa.--(BW HealthWire)--July 13, 2001-- EQUIDYNE
CORPORATION (AMEX:IJX - news) announced today it has expanded its marketing
agreement with Rite Aid Corporation (NYSE:RAD - news), (PCX:RAD) to include
``direct-to-consumer'' promotions through the national pharmacy chain's 3,600
neighborhood stores in 30 states relating to the INJEX(TM) System. Additionally, Equidyne
representatives have been working with Rite Aid at the local level scheduling patient
awareness events to educate people with diabetes about the benefits of using INJEX(TM)
for insulin administration. Several events have been held throughout the country and more are
scheduled over the next several months.
J. Randall Nelson, Chairman and Chief Executive Officer of Equidyne, stated, ``We have
been extremely pleased with our association with Rite Aid and this expansion of our
relationship will accelerate Equidyne's consumer-oriented marketing strategy. Extensive
focus group research with both doctors and consumers show a pent-up demand for
information about the INJEX(TM) needle-free devise and how it can be used to deliver
insulin. People with diabetes want to know where to obtain it and how to use it, and health
care professionals are willing to prescribe and train patients in the proper use of
INJEX(TM). This new partnership with Rite Aid will help us reach more customers who can
benefit from the INJEX(TM) System.''
``We are excited about working with Equidyne to increase consumer awareness of the
INJEX(TM) products, and providing our insulin customers with leading edge insulin delivery
products,'' said Greg Drew, Rite Aid Vice President, Pharmacy Health Services.
Gotta keep up the momemtum here...down and out for a few with the rest of the bio industry.
looking for a healthy rebound.
CC |
